2734168-78-4
Chemical Structure
HPK1-IN-9
- CAS No.: 2734168-78-4
- Formula:C30H33N7O2
- Molecular Weight:523.63
IUPAC Name: (3-(dimethylamino)azetidin-1-yl)(4-(2-(3-methyl-1,2,3,4,4a,5-hexahydrobenzo[b]pyrazino[1,2-d][1,4]oxazin-8-yl)-5H-pyrrolo[2,3-b]pyrazin-7-yl)phenyl)methanone
InChIKey: HOCZDMHZECLMJQ-UHFFFAOYSA-N
SMILES: O=C(N1CC(C1)N(C)C)C2=CC=C(C3=CNC4=C3N=C(C5=CC=C6C(OCC7N6CCN(C7)C)=C5)C=N4)C=C2
Biological Activity: HPK1-IN-9 is potent inhibitor of HPK1. HPK1 is a serine/threonine protein kinase cloned from hematopoietic progenitor cells and belongs to the MAP4K family of mammalian Ste-20-related protein kinases. HPK1-IN-9 has the potential for the research of HPK1 related diseases (extracted from patent WO2021213317A1, compound 112) [1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
HPK1-IN-9 | HPK1-IN-9 is potent inhibitor of HPK1. HPK1 is a serine/threonine protein kinase cloned from hematopoietic progenitor cells and belongs to the MAP4K family of mammalian Ste-20-related protein kinases. HPK1-IN-9 has the potential for the research of HPK1 related diseases (extracted from patent WO2021213317A1, compound 112) . | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
